B.C. government ferry cuts set coastal aboriginal tourism efforts adrift

By Dirk Meissner, The Canadian Press

VICTORIA – Aboriginal entrepreneurs looking to develop home-grown tourism ventures along British Columbia’s coast say their plans have been set adrift by Liberal government route cuts at BC Ferries.

The government’s decision to sink the money-losing summer run between Port Hardy on Vancouver Island and Bella Coola on the Central Coast has prompted one First Nation and a major tourism agency to re-evalutate their tourism strategies.

After investing $1.5 million over the past two years, the Aboriginal Tourism Association of B.C. says the impending cuts to ferry service forced it to gear down campaigns to train coastal First Nations to embrace tourism opportunities.

What’s the point going full-speed-ahead on tourism when the government has left operators and residents with the 16-vehicle, barge-like MV Nimpkish, to provide a milk-run service for the nine-hour voyage from Bella Bella to Bella Coola, says Keith Henry, the association’s chief executive officer.

Transportation Minister Todd Stone says the government and B.C. taxpayers can’t keep bailing out BC Ferries, which is why service and route cuts are coming next month in an effort to hold down fare increases and keep the service sustainable.

Henry said the decision to eliminate Route 40, or the Discovery Coast route, this year downgrades the Central Coast’s circle tour travel package that included a 115-vehicle vessel with full services that made stops at the traditional communities of Bella Bella, Klemtu, Ocean Falls and Bella Coola, where travellers would get off to take a land journey through the Cariboo-Chilcotin to the Lower Mainland.

BC Ferries will continue to sail the Northern Expedition from Port Hardy to Prince Rupert, with a stop at Bella Bella. But at Bella Bella tourists and locals would have to board the MV Nimpkish, currently undergoing a refit to install seats, interior heat and potable water, for the voyage up the fjord to Bella Coola.

“Organizations like ours, we’re doing a lot to try and bring more people through,” Henry said in an interview. “That’s critical to our success. But if we can’t get visitors there efficiently, that’s unfortunate.

“I can tell you confidently, we’ve started to minimize our investments around training and product development.”

The association sent Premier Christy Clark a letter last December outlining its concerns about the impending cuts.

“The proposed BC Ferries reductions will have an immediate and significant negative financial impact to aboriginal market-ready businesses and product development work currently in the regions of Vancouver Island, Vancouver coast and mountains, Cariboo Chilcotin coast and northern British Columbia,” stated the letter.

It stated the tourism association initiated travel plans for almost 140 communities along the Central Coast, Vancouver Island, Cariboo-Chilcotin and northwest B.C., but the cuts will be felt region wide.

Henry said the numbers of travellers wanting an aboriginal tourism experience in B.C. are increasing every year, and he believes it’s tied to the authenticity being offered travellers. Aboriginal tourism in B.C. earned $45 million last year, up from $20 million in 2012.

The Tourism Industry Association of B.C. also publicly expressed concern about the impact of the ferry service and route cuts.

“The timing of this announcement couldn’t have been worse,” said Ian Robertson, association executive director in a statement last month. “Tourism operators in these regions have been receiving bookings for the 2014 season for months, and now they will have to be cancelled. This decision means that they will definitely lose revenue and jobs — and many may lose their businesses.”

Stone was not available to comment, but his ministry provided a statement saying it is aware cuts will hurt but the government’s goal is to run an affordable, efficient, sustainable ferry system .

“We have heard from business communities, First Nations and the public in general during our consultations over the last two years,” said the statement. “These are tough decisions to make. We recognize that any reduction in service will impact ferry users.”

Earlier, Stone said Route 40 was underutilized and expensive, with the losses adding up to a $2,500 subsidy for each passenger.

Premier Christy Clark has said her government will do what it can to support and include aboriginals in economic development.

“I intend to make sure that economic development finds its way into First Nations communities,” she said.

BC Ferries is expected to make $54 million in cuts through efficiencies by 2016 and the service reductions are estimated to save $18.9 million over two years, while fares are set to increase four per cent this year and 3.9 per cent in 2015.

Last month, Stone released the results of a public consultation report that confirmed the Liberals would proceed with cuts despite public opposition and calls for an analysis of the impact cuts on local economies.

“I don’t know what goes on in the legislature, but it strikes me they are looking at it from one viewpoint only,” said Randy Hart, president and chief executive officer of the Nuxalk Development Corporation at Bella Coola.

“We felt pretty confident that we would be able to improve the ridership on that ferry,” he said.

Hart said the Nuxalk Nation started its for-profit company in Bella Coola to target tourism, but with the summer ferry service cancelled, plans are now underway to attract fly-in only tourists for exclusive wilderness tours and expeditions.

“We see tourism as an employment generator and as a way to participate in the non-extractive resource industry,” he said. “Personally, I never thought they would go as far as they did. I thought there would be a compromise.”

University of B.C. economic geography Prof. Ken Denike said cutting the ferry service to the Central Coast will prove disastrous because it cuts off business networks and prevents new ones from emerging.

The Vancouver school trustee said the replacement of the summer ferry with the MV Nimpkish will sink tourism in the area.

“Putting a boat like a barge on there, which is what they are proposing to do, is ridiculous,” he said. “It’s going to give the tourists a real ride, but they won’t be back.”

Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Most Watched Today